Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

DNA sequencing of cytopathologically inconclusive EUS-FNA from solid pancreatic lesions suspicious for malignancy confirms EUS diagnosis

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. EUS-guided through-the-needle microbiopsy of pancreatic cysts: Technical aspects (with video)

    Research output: Contribution to journalReviewResearchpeer-review

  2. What should be known prior to performing EUS exams? (Part II)

    Research output: Contribution to journalReviewResearchpeer-review

  3. A multi-institution consensus on how to perform EUS-guided biliary drainage for malignant biliary obstruction

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Impact of the COVID-19 pandemic on gastrointestinal endoscopy in Africa

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. EUS-guided through-the-needle microbiopsy of pancreatic cysts: Technical aspects (with video)

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

Background and Objectives: EUS-FNA is inconclusive in up to 10%-15% of patients with solid pancreatic lesions (SPLs). We aimed to investigate whether supplementary genetic analyses with whole-exome sequencing add diagnostic value in patients with SPLs suspicious of malignancy but inconclusive EUS-FNA.

Patients and Methods: Thirty-nine patients, who underwent EUS-FNA of an SPL were retrospectively included. Three groups were defined: 16 (41.0%) had suspected malignancy on EUS confirmed by cytology (malignant), 13 (33.3%) had suspected malignancy on EUS but benign cytology (inconclusive), and 10 (25.6%) had benign EUS imaging and cytology (benign). Areas with the highest epithelial cell concentrations were macro-dissected from the FNA smears from each patient, and extracted DNA was used for whole-exome sequencing by next-generation sequencing of a selected gene panel including 19 genes commonly mutated in cancer.

Results: Pathogenic mutations in K-RAS, TP53, and PIK3CA differed significantly between the three groups (P < 0.001, P = 0.018, and P = 0.026, respectively). Pathogenic mutations in KRAS and TP53 were predominant in the inconclusive (54% and 31%, respectively) and malignant groups (81.3% and 50%, respectively) compared to the benign group (0%). Malignant and inconclusive diagnoses correlated strongly with poor overall survival (P < 0.001).

Conclusion: Whole-exome sequencing of genes commonly mutated in pancreatic cancer may be an important adjunct in patients with SPLs suspicious for malignancy on EUS but with uncertain cytological diagnosis.

Original languageEnglish
JournalEndoscopic Ultrasound
Volume9
Issue number1
Pages (from-to)37-44
Number of pages8
ISSN2303-9027
DOIs
Publication statusPublished - Jan 2020

    Research areas

  • Diagnostics, EUS-FNA, next-generation sequencing, Pancreatic ductal adenocarcinoma, Whole-exome sequencing

ID: 58033330